PE-backed Synlab announces IPO intention
Germany-based laboratory diagnostic services business Synlab, which is backed by sponsors including Cinven, has announced that it intends to list on the Frankfurt Stock Exchange.
More on Investments
PE-backed diagnostics firm Synlab announces IPO pricing
Shares will be priced at €18-23, equating to a €4-5bn market capitalisation and €5.9-6.9bn EV
Buyout rankings: who invested the most in Europe in Q1 2021?
Unquote tallies the top 10 most active GPs across the European buyout space in the first quarter
PE players seek opportunities in minority deals, differentiated strategies
Minority investments, co-investments and other creative deals made via differentiated strategies could become even more relevant post-pandemic
Q&A: Debevoise's Bet-Mansour and Scoville on Spacs' relevance for PE
The partners share their thoughts on why Spacs are so attractive, what sponsors should be wary of, and whether they expect a similar uptake in Europe
Latest News
Forbion Growth Opportunities I holds €360m final close
Strategy will target later-stage life sciences businesses, as well as undervalued listed companies
Primo Digital Fund launches with €80m target
Fund has a special focus on the e-commerce, software, cybersecurity, fintech and blockchain sectors
Swedish VC Pale Blue Dot closes debut Climate Tech Fund on €87m
GP is looking to invest in 35 tech startups in Europe and the US that are focused on the climate
Van den Ende sells stake in Endeit Capital
Partners Hubert Deitmers and Martijn Hamann will now be the sole owners of the firm